Harbour Investments, Inc. Jounce Therapeutics, Inc. Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$7.11 - $9.64 $554 - $751	-78 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.04 - $8.73 $20 - $34	4 Added 5.41%	78 $1,000
Q2 2021 Aug 16, 2021	BUY	$6.58 - $10.66 $177 - $287	27 Added 57.45%	74 $1,000
Q1 2021 Aug 17, 2021	BUY	$6.73 - $13.87 $316 - $651	47 New	47 $0

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.